BACKGROUND: The delayed release of serum cardiac markers such as creatine kinase isoenzyme MB and equivocal early electrocardiographic changes have hampered a diagnosis of acute myocardial infarction (AMI) in the early phase after its onset. Therefore, a reliable serum biochemical marker for the diagnosis of AMI in the very early phase is desirable. METHODS AND RESULTS: Serum samples were collected from the patients with AMI, unstable angina pectoris, stable angina pectoris, and other diseases. Levels of serum deoxyribonuclease I (DNase I) activity in the patients were determined. An abrupt elevation of serum DNase I activity was observed within approximately 3 hours of the onset of symptoms in patients with AMI, with significantly higher activity levels (21.7+/-5.10 U/L) in this group compared with the other groups with unstable angina pectoris (10.4+/-4.41 U/L), angina pectoris (10.8+/-3.70 U/L), and other diseases (9.22+/-4.16 U/L). Levels of the DNase I activity in serum then exhibited a marked time-dependent decline within 12 hours and had returned to basal levels within 24 hours. CONCLUSIONS: We suggest that serum DNase I activity could be used as a new diagnostic marker for the early detection of AMI.
BACKGROUND: The delayed release of serum cardiac markers such as creatine kinase isoenzyme MB and equivocal early electrocardiographic changes have hampered a diagnosis of acute myocardial infarction (AMI) in the early phase after its onset. Therefore, a reliable serum biochemical marker for the diagnosis of AMI in the very early phase is desirable. METHODS AND RESULTS: Serum samples were collected from the patients with AMI, unstable angina pectoris, stable angina pectoris, and other diseases. Levels of serum deoxyribonuclease I (DNase I) activity in the patients were determined. An abrupt elevation of serum DNase I activity was observed within approximately 3 hours of the onset of symptoms in patients with AMI, with significantly higher activity levels (21.7+/-5.10 U/L) in this group compared with the other groups with unstable angina pectoris (10.4+/-4.41 U/L), angina pectoris (10.8+/-3.70 U/L), and other diseases (9.22+/-4.16 U/L). Levels of the DNase I activity in serum then exhibited a marked time-dependent decline within 12 hours and had returned to basal levels within 24 hours. CONCLUSIONS: We suggest that serum DNase I activity could be used as a new diagnostic marker for the early detection of AMI.
Authors: Simon F De Meyer; Georgette L Suidan; Tobias A Fuchs; Marc Monestier; Denisa D Wagner Journal: Arterioscler Thromb Vasc Biol Date: 2012-05-24 Impact factor: 8.311
Authors: Julian I Borissoff; Ivo A Joosen; Mathijs O Versteylen; Alexander Brill; Tobias A Fuchs; Alexander S Savchenko; Maureen Gallant; Kimberly Martinod; Hugo Ten Cate; Leonard Hofstra; Harry J Crijns; Denisa D Wagner; Bas L J H Kietselaer Journal: Arterioscler Thromb Vasc Biol Date: 2013-07-01 Impact factor: 8.311
Authors: Thomas M Hofbauer; Andreas Mangold; Anna S Ondracek; Adelheid Panzenböck; Thomas Scherz; Julian Müller; Klaus Distelmaier; Veronika Seidl; Stefan Kastl; Martina Müller-Nurasyid; Annette Peters; Konstantin Strauch; Robert Winker; Evelyne Wohlschläger-Krenn; Sonja Nistler; Irene M Lang Journal: Basic Res Cardiol Date: 2021-04-23 Impact factor: 17.165